showed that TGF-β chimeric antigen receptor (CAR) T cells promoted the anti-tumor immune response by alleviating TGF-β-mediated immunosuppression, and reduced Foxp3+ Treg differentiation (123). This evidence concerns the gene TGFB1 and neoplasm.